Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

News
Most Providers Satisfied With Pandemic Shift to Telepsychiatry
12/09/2021
A recent study finds clinicians who shifted to telepsychiatry in 2020 and 2021 reported high overall satisfaction with remote care.
A recent study finds clinicians who shifted to telepsychiatry in 2020 and 2021 reported high overall satisfaction with remote care.
A recent study finds clinicians...
12/09/2021
Psych Congress Network
News
Extended-release Amphetamine Tablet Demonstrates Efficacy for Adult ADHD
12/09/2021
An extended-release amphetamine tablet demonstrated efficacy and an anticipated safety profile in adults with ADHD, researchers reported in a poster presentation at Psych Congress 2021.
An extended-release amphetamine tablet demonstrated efficacy and an anticipated safety profile in adults with ADHD, researchers reported in a poster presentation at Psych Congress 2021.
An extended-release amphetamine...
12/09/2021
Psych Congress Network

Advertisement

News
Delix Partners With NIDA to Study Ibogaine Analog to Treat Multiple SUDs
12/09/2021
Delix Therapeutics has partnered with the National Institute on Drug Abuse to study the use of its DLX-7 ibogaine analog to treat multiple substance use disorders.
Delix Therapeutics has partnered with the National Institute on Drug Abuse to study the use of its DLX-7 ibogaine analog to treat multiple substance use disorders.
Delix Therapeutics has partnered...
12/09/2021
Psych Congress Network
News
Valbenazine Use for Tardive Dyskinesia in Older Adults Proves Efficacious
12/08/2021
Valbenazine use for tardive dyskinesia (TD) in adults aged 65 and older has been deemed efficacious with comparable outcomes to younger adults, according to a post hoc analysis.
Valbenazine use for tardive dyskinesia (TD) in adults aged 65 and older has been deemed efficacious with comparable outcomes to younger adults, according to a post hoc analysis.
Valbenazine use for tardive...
12/08/2021
Psych Congress Network
News
Generalized Anxiety Disorder Affects 1 in 4 Adults with ADHD
12/06/2021
New study results in a nationally representative survey suggest 1 in 4 adults ages 20 to 39 with ADHD also have generalized anxiety disorder.
New study results in a nationally representative survey suggest 1 in 4 adults ages 20 to 39 with ADHD also have generalized anxiety disorder.
New study results in a...
12/06/2021
Psych Congress Network

Advertisement

News
Deutetrabenazine is Beneficial for Long-Term Tardive Dyskinesia Treatment
12/03/2021
Deutetrabenazine may provide long-term treatment benefits to patients with tardive dyskinesia (TD), according to a post hoc analysis presented in a poster at Psych Congress 2021.
Deutetrabenazine may provide long-term treatment benefits to patients with tardive dyskinesia (TD), according to a post hoc analysis presented in a poster at Psych Congress 2021.
Deutetrabenazine may provide...
12/03/2021
Psych Congress Network
News
Yale Researchers Receive Grant From Michael J. Fox Foundation to Study Use of Ketamine for Depression in Parkinson’s Patients
12/03/2021
The Yale University School of Medicine announced that 2 researchers from its Department of Psychiatry have been awarded a $2 million grant from the Michael J. Fox Foundation for Parkinson’s Research to conduct the first clinical trial for the...
The Yale University School of Medicine announced that 2 researchers from its Department of Psychiatry have been awarded a $2 million grant from the Michael J. Fox Foundation for Parkinson’s Research to conduct the first clinical trial for the...
The Yale University School of...
12/03/2021
Psych Congress Network
News
Report Offers Creative Solutions to Rural Mental Health Care Obstacles
12/02/2021
SMI Adviser, in partnership with the NASMHPD and the NASMHPD Research Institute, has published a report on how to improve the availability, accessibility, and acceptability of mental health care in rural and remote areas.
SMI Adviser, in partnership with the NASMHPD and the NASMHPD Research Institute, has published a report on how to improve the availability, accessibility, and acceptability of mental health care in rural and remote areas.
SMI Adviser, in partnership with...
12/02/2021
Psych Congress Network

Advertisement

News
Elizabeth Smart: The Story Beyond the Trauma
12/02/2021
Elizabeth Smart gives a moving and emotional keynote address about her journey after trauma.
Elizabeth Smart gives a moving and emotional keynote address about her journey after trauma.
Elizabeth Smart gives a moving...
12/02/2021
Psych Congress Network
News
Yalom Sees Formula for Helping Patients Address ‘Death Anxiety’
12/01/2021
In an Evolution of Psychotherapy keynote interview, Irv Yalom, MD, professor emeritus of psychiatry at the Stanford University School of Medicine, said helping patients find ways to work toward a regret-free life can help lessen the burden of...
In an Evolution of Psychotherapy keynote interview, Irv Yalom, MD, professor emeritus of psychiatry at the Stanford University School of Medicine, said helping patients find ways to work toward a regret-free life can help lessen the burden of...
In an Evolution of Psychotherapy...
12/01/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use